Presentation
Pharmacology
Bioavailability
What is Bioavailability?
• Bioavailability: It is a measure of the fraction (F )
of administered dose of a drug that reaches the
systemic circulation in the unchanged form.
• bioavailability may be less than 100% for two main
reasons:
• incomplete extent of absorption across the gut
wall and
• first-pass elimination by the liver
• In such cases, the dose available to the patient
called as Bioavailable dose. It often less than the
administered dose.
• The amount of drug that reaches the systemic
circulation is called as Systemic availability.
• The term bioavailable Fraction F refers to the
fraction of administered dose that enters the
systemic circulation.
TABLE: Routes of administration,
bioavailability, and general characteristics.
Factors affecting Bioavailability
• There are various factors which affect
bioavailability.
 Pharmaceutical Factors.
 Pharmacological factors.
 Route of administration.
Pharmaceutical factors
Particle size
Salt form
Crystal form
Nature of Excipients
Degree of ionization
Partition coefficient
Pharmacological factors include:
• Gastric emptying and gastrointestinal motility.
• Gastrointestinal diseases.
• Food and other substances.
• First pass metabolism.
• Drug-drug interactions.
Route of administration
• Parenteral
• Oral
• Topical
• Rectal
• Inhalation.
Types of Bioavailability
• There are two types of Bioavailability
1. Absolute Bioavailability
2. Relative Bioavailability
Absolute Bioavailability
1.Absolute Bioavailability: when the systemic
availability of a drug administered orally is
comparison to its intravenous administration. Is
known as absolute bioavailability
Relative Bioavailability
• The relative Bioavailability is the systemic
availability of a drug administered orally is
determined by doing its comparison with that of
an oral standard of same drug.
Conti..
• Range of Biovailability -0 to 1
• It is usually expressed as percentages (%)
• An Absolute Bioavailability of 1 (or 100%)
indicates complete absorption.
• Relative Bioavailability of 1 (or 100%)
implies that the Bioavailability of drug from
both dosage forms is same but does not
indicate the completeness of the systemic
drug absorption.
Methods of assessing Bioavailability
• Pharmacokinetic methods (Indirect)
1. Blood analysis.
2. Urinary excretion data
Pharmacokinetic method(Indirect)
Blood analysis
• Plasma level time studies or the plasma
concentration - time curve or blood level
curve.
• A direct relationship exists concentration of
drug at the site of action and concentration of
drug in the plasma.
• Serial blood samples are taken after drug
administration and analyzed for drug
concentration.
• A typical blood level curve obtained after
oral administration of drug.
Urine excretion data
• The method of determination bioavailability
provided that the active ingredient is excreted
unchanged in the significant quantity of
urine.
• The cumulative amount of active drug
excreted in urine is directly proportional to
extent of systemic circulation.
• The rate of drug excretion is directly
proportional to rate of systemic drug
absorption.
Pharmacokinetic parameters
• Peak plasma concentration (Cmax).
• Time of peak concentration(Tmax).
• Area under curve (AUC)
AUC or extent of absorption
can be measured by 3 methods
•Planimeter: Instrument for mechanically
measuring the area.
•Cut and weigh method:
AUC is cut and weighed on analytical palace.
The weight obtained is converted to proper
unit by dividing it by the weight of a unit area
of same paper.
•Trapeziodal method.

Presentation Bioavailability.pptx

  • 1.
  • 2.
    What is Bioavailability? •Bioavailability: It is a measure of the fraction (F ) of administered dose of a drug that reaches the systemic circulation in the unchanged form. • bioavailability may be less than 100% for two main reasons: • incomplete extent of absorption across the gut wall and • first-pass elimination by the liver
  • 3.
    • In suchcases, the dose available to the patient called as Bioavailable dose. It often less than the administered dose. • The amount of drug that reaches the systemic circulation is called as Systemic availability. • The term bioavailable Fraction F refers to the fraction of administered dose that enters the systemic circulation.
  • 4.
    TABLE: Routes ofadministration, bioavailability, and general characteristics.
  • 5.
    Factors affecting Bioavailability •There are various factors which affect bioavailability.  Pharmaceutical Factors.  Pharmacological factors.  Route of administration.
  • 7.
    Pharmaceutical factors Particle size Saltform Crystal form Nature of Excipients Degree of ionization Partition coefficient
  • 8.
    Pharmacological factors include: •Gastric emptying and gastrointestinal motility. • Gastrointestinal diseases. • Food and other substances. • First pass metabolism. • Drug-drug interactions.
  • 10.
    Route of administration •Parenteral • Oral • Topical • Rectal • Inhalation.
  • 11.
    Types of Bioavailability •There are two types of Bioavailability 1. Absolute Bioavailability 2. Relative Bioavailability
  • 12.
    Absolute Bioavailability 1.Absolute Bioavailability:when the systemic availability of a drug administered orally is comparison to its intravenous administration. Is known as absolute bioavailability
  • 13.
    Relative Bioavailability • Therelative Bioavailability is the systemic availability of a drug administered orally is determined by doing its comparison with that of an oral standard of same drug.
  • 14.
    Conti.. • Range ofBiovailability -0 to 1 • It is usually expressed as percentages (%) • An Absolute Bioavailability of 1 (or 100%) indicates complete absorption. • Relative Bioavailability of 1 (or 100%) implies that the Bioavailability of drug from both dosage forms is same but does not indicate the completeness of the systemic drug absorption.
  • 16.
    Methods of assessingBioavailability • Pharmacokinetic methods (Indirect) 1. Blood analysis. 2. Urinary excretion data
  • 17.
    Pharmacokinetic method(Indirect) Blood analysis •Plasma level time studies or the plasma concentration - time curve or blood level curve. • A direct relationship exists concentration of drug at the site of action and concentration of drug in the plasma.
  • 18.
    • Serial bloodsamples are taken after drug administration and analyzed for drug concentration. • A typical blood level curve obtained after oral administration of drug.
  • 19.
    Urine excretion data •The method of determination bioavailability provided that the active ingredient is excreted unchanged in the significant quantity of urine. • The cumulative amount of active drug excreted in urine is directly proportional to extent of systemic circulation. • The rate of drug excretion is directly proportional to rate of systemic drug absorption.
  • 20.
    Pharmacokinetic parameters • Peakplasma concentration (Cmax). • Time of peak concentration(Tmax). • Area under curve (AUC)
  • 22.
    AUC or extentof absorption can be measured by 3 methods •Planimeter: Instrument for mechanically measuring the area. •Cut and weigh method: AUC is cut and weighed on analytical palace. The weight obtained is converted to proper unit by dividing it by the weight of a unit area of same paper. •Trapeziodal method.